Medpace Holdings, Inc. — Form SCHEDULE 13D/A
Filed September 28, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
August J. Troendle filed an amended Schedule 13D/A regarding beneficial ownership in Medpace Holdings, Inc. (NASDAQ: MEDP). The filing itself does not disclose in the header the specific ownership percentage, share count, or dollar amount of the amendment, nor does it state what changed from the prior disclosure. A Schedule 13D/A amendment typically indicates a change in beneficial ownership position that must be reported, but the substantive details are not visible in the metadata provided.
Why this rating
Schedule 13D amendments are routine regulatory filings when beneficial ownership stakes change. Without knowing the actual percentage change, share count, or whether this represents a material shift in control (Troendle is Medpace's founder/CEO), cannot assess if this is a major position move. Relative to $7B market cap, most routine stake adjustments are immaterial unless crossing 5% threshold or indicating major transaction.
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.